New ovarian cancer treatment guidelines announced

A new guideline issued by the Society of Gynecologic Oncology (SGO) and American Society of Clinical Oncology (ASCO) provides evidence-based recommendations on whether to use chemotherapy or surgery in the initial treatment of women with epithelial ovarian cancer. Epithelial ovarian cancer is when cancer cells form in the tissue of the ovary and accounts for 70 to 80 percent of all ovarian cancers.

The following are the key guideline recommendations issued:

  • All patients with a possible diagnosis of advanced stage (III or IV) ovarian cancer should be evaluated by a gynecologic oncologist PRIOR to starting any therapy.
  • A gynecologic oncologist will determine if surgery is an option prior to chemotherapy.
  • The goal of surgery is to remove all visible tumor to less than 1 cm, ideally to no visible disease.
  • Neoadjuvant chemotherapy (chemotherapy given prior to surgery) should be offered if there is little chance to remove all visible tumor OR if the patient has a high complication risk from surgery.
The guideline is now available, along with supplementary materials. For more information about ovarian cancer, access the resources available on our site.


Couldn’t make it to the National Race to End Women’s Cancer? You can still support women with gynecologic cancers by making a contribution today.


September is Gynecologic Cancer Awareness Month. #GCAM


The FWC is proud to offer various Research Grants and Awards. Click here for more information.


FREE Gynecologic Cancer Education Courses throughout the country. For more information, click here.